Assessing the effect of food mycotoxins on aromatase by using a cell-based system

Toxicology in Vitro

Volumn 28, Issue 4, 2014, Pages 640-646

  Wang, Yanfei ^a,b   Wong, Tsz Yan ^b   Chan, Franky L ^c   Chen, Shiuan ^d   Leung, Lai K ^b  

^a SHANDONG UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Aflatoxin B1; Aromatase; Zearalenone; Zeranol

Indexed keywords

AFLATOXIN B1; AROMATASE; ZEARALENONE; ZERANOL; CYP19A1 PROTEIN, HUMAN; MESSENGER RNA;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME REPRESSION; PROTEIN EXPRESSION; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PROMOTER REGION;

AROMATASE; CELL LINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; ZEARALENONE; ZERANOL;

EID: 84896733452     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.01.012     Document Type: Article

References (37)

1. Bedard L.L., Massey T.E. Aflatoxin B1-induced DNA damage and its repair. Cancer Lett. 2006, 241:174-183.
2. Bennett J.W., Klich M. Mycotoxins. Clin. Microbiol. Rev. 2003, 16:497-516.
3. Bulun S.E., Sebastian S., Takayama K., Suzuki T., Sasano H., Shozu M. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J. Steroid Biochem. Mol. Biol. 2003, 86:219-224.
4. Cagnacci A., Soldani R., Carriero P.L., Paoletti A.M., Fioretti P., Melis G.B. Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women. J. Clin. Endocrinol. Metab. 1992, 74:1396-1400.
5. Chand A.L., Simpson E.R., Clyne C.D. Aromatase expression is increased in BRCA1 mutation carriers. BMC Cancer 2009, 9:148.
6. Dixon S.N., Russell K.L., Heitzman R.J., Mallinson C.B. Radioimmunoassay of the anabolic agent zeranol. V. Residues of zeranol in the edible tissues, urine, faeces and bile of steers treated with Ralgro. J. Vet. Pharmacol. Ther. 1986, 9:353-358.
7. EFSA-Panel Scientific opinion on the risks for public health related to the presence of zearalenone in food. EFSA J. 2011, 9:2197.
8. Frizzell C., Ndossi D., Kalayou S., Eriksen G.S., Verhaegen S., Sorlie M., Elliott C.T., Ropstad E., Connolly L. An in vitro investigation of endocrine disrupting effects of the mycotoxin alternariol. Toxicol. Appl. Pharmacol. 2013, 271:64-71.
9. Huang H., Leung L.K. Bisphenol A downregulates CYP19 transcription in JEG-3 cells. Toxicol. Lett. 2009, 189:248-252.
10. Huuskonen P., Myllynen P., Storvik M., Pasanen M. The effects of aflatoxin B1 on transporters and steroid metabolizing enzymes in JEG-3 cells. Toxicol. Lett. 2013, 218:200-206.
11. Kamat A., Hinshelwood M.M., Murry B.A., Mendelson C.R. Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrinol. Metab. 2002, 13:122-128.
12. Lacey M., Bohday J., Fonseka S.M., Ullah A.I., Whitehead S.A. Dose-response effects of phytoestrogens on the activity and expression of 3beta-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells. J. Steroid Biochem. Mol. Biol. 2005, 96:279-286.
13. Lambard S., Silandre D., Delalande C., Denis-Galeraud I., Bourguiba S., Carreau S. Aromatase in testis: expression and role in male reproduction. J. Steroid Biochem. Mol. Biol. 2005, 95:63-69.
14. Lephart E.D., Simpson E.R. Assay of aromatase activity. Methods Enzymol. 1991, 206:477-483.
15. Li F., Ye L., Lin S.M., Leung L.K. Dietary flavones and flavonones display differential effects on aromatase (CYP19) transcription in the breast cancer cells MCF-7. Mol. Cell. Endocrinol. 2011, 344:51-58.
16. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
17. Means G.D., Mahendroo M.S., Corbin C.J., Mathis J.M., Powell F.E., Mendelson C.R., Simpson E.R. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J. Biol. Chem. 1989, 264:19385-19391.
18. Mendelson C.R., Kamat A. Mechanisms in the regulation of aromatase in developing ovary and placenta. J. Steroid Biochem. Mol. Biol. 2007, 106:62-70.
19. Morishima A., Grumbach M.M., Simpson E.R., Fisher C., Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 1995, 80:3689-3698.
20. Olson S.H., Bandera E.V., Orlow I. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Am. J. Epidemiol. 2007, 165:235-245.
21. Rhyn P., Zoller O. Zearalenone in cereals for human nutrition: relevant data for the Swiss population. Eur. Food Res. Technol. 2003, 216.
22. Richard J.L. Some major mycotoxins and their mycotoxicoses-an overview. Int. J. Food Microbiol. 2007, 119:3-10.
23. Simpson E.R., Michael M.D., Agarwal V.R., Hinshelwood M.M., Bulun S.E., Zhao Y. Cytochromes P450 11: expression of the CYP19 (aromatase) gene: an unusual case of alternative promoter usage. FASEB J. 1997, 11:29-36.
24. Sirot V., Fremy J.M., Leblanc J.C. Dietary exposure to mycotoxins and health risk assessment in the second French total diet study. Food Chem. Toxicol. 2013, 52:1-11.
25. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., Williams T.C., Lubahn D.B., Korach K.S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 1994, 331:1056-1061.
26. Storvik M., Huuskonen P., Kyllonen T., Lehtonen S., El-Nezami H., Auriola S., Pasanen M. Aflatoxin B1-a potential endocrine disruptor-up-regulates CYP19A1 in JEG-3 cells. Toxicol. Lett. 2011, 202:161-167.
27. Streit E., Schatzmayr G., Tassis P., Tzika E., Marin D., Taranu I., Tabuc C., Nicolau A., Aprodu I., Puel O., Oswald I.P. Current situation of mycotoxin contamination and co-occurrence in animal feed-focus on Europe. Toxins (Basel) 2012, 4:788-809.
28. Tan W., Wong T.Y., Wang Y., Huang J., Leung L.K. CYP19 expression is induced by 2,3,7,8-tetrachloro-dibenzo-para-dioxin in human glioma cells. Mol. Cell. Endocrinol. 2013, 375:106-112.
29. Toda K., Terashima M., Kawamoto T., Sumimoto H., Yokoyama Y., Kuribayashi I., Mitsuuchi Y., Maeda T., Yamamoto Y., Sagara Y., et al. Structural and functional characterization of human aromatase P-450 gene. Eur. J. Biochem. 1990, 193:559-565.
30. Tuckerman E., Laird S.M., Stewart R., Wells M., Li T.C. Markers of endometrial function in women with unexplained recurrent pregnancy loss: a comparison between morphologically normal and retarded endometrium. Hum. Reprod. 2004, 19:196-205.
31. Wang Y., Chan F.L., Chen S., Leung L.K. The plant polyphenol butein inhibits testosterone-induced proliferation in breast cancer cells expressing aromatase. Life Sci. 2005, 77:39-51.
32. Wang Y., Lee K.W., Chan F.L., Chen S., Leung L.K. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicol. Sci. 2006, 92:71-77.
33. Wang Y., Leung L.K. Pharmacological concentration of resveratrol suppresses aromatase in JEG-3 cells. Toxicol. Lett. 2007, 173:175-180.
34. Wang Y., Man Gho W., Chan F.L., Chen S., Leung L.K. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression. Br. J. Nutr. 2008, 99:303-310.
35. Whitehead S.A., Lacey M. Phytoestrogens inhibit aromatase but not 17beta-hydroxysteroid dehydrogenase (HSD) type 1 in human granulosa-luteal cells: evidence for FSH induction of 17beta-HSD. Hum. Reprod. 2003, 18:487-494.
36. Yallampalli C., Byam-Smith M., Nelson S.O., Garfield R.E. Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology 1994, 134:1971-1974.
37. Ye L., Chan M.Y., Leung L.K. The soy isoflavone genistein induces estrogen synthesis in an extragonadal pathway. Mol. Cell. Endocrinol. 2009, 302:73-80.